[2 cases of infective endocarditis due to Actinobacillus actinomycetemcomitans]. 1983

K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura

UI MeSH Term Description Entries
D008297 Male Males
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000188 Actinobacillus A genus of PASTEURELLACEAE described as gram-negative, nonsporeforming, nonmotile, facultative anaerobes. Most members are found both as pathogens and commensal organisms in the respiratory, alimentary, and genital tracts of animals.
D000189 Actinobacillus Infections Infections with bacteria of the genus ACTINOBACILLUS. Infections, Actinobacillus,Actinobacillus Infection,Infection, Actinobacillus
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
January 1984, Acta clinica Belgica,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
March 1975, British medical journal,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
June 1968, Canadian journal of medical technology,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
March 1985, The Journal of infection,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
February 2002, Revista clinica espanola,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
October 1967, The American journal of medicine,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
July 1967, Archives of internal medicine,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
July 1980, Mayo Clinic proceedings,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
January 1983, The American journal of the medical sciences,
K Naomasa, and K Nozawa, and K Takeda, and K Yoshimura
January 1981, Scandinavian journal of infectious diseases,
Copied contents to your clipboard!